Table 2.
Baseline data of patients (n=28).
| Variables | n (%) or mean ± SD |
|---|---|
| Female/ male | 17 (61%) / 11 (39%) |
| Age, years* | 54± 13 |
| BMI, kg/m2* | 26 ± 5 |
| Smoking history | 7(25%) |
| Schooling, n (%) | |
| Elementary school | 17 (60.7%) |
| High school | 10 (35.7%) |
| Higher education | 1 (3.6%) |
| Causes, n (%) | |
| Postinfectious | 10 (36%) |
| Ciliary dyskinesia | 4 (14%) |
| COPD | 6 (21%) |
| Idiopathic | 5 (18%) |
| Others° | 10 (36%) |
| Medicine in use, n (%) | |
| Inhaled corticosteroid | 26 (93%) |
| Long action Beta 2 agonist | 27 (96%) |
| Short action Beta 2 agonist | 5 (18%) |
| Macrolides | 9 (32%) |
| Pulmonary function* | |
| FVC (L) | 2.3 ± 0.7 |
| FVC (% predicted) | 64.3 ± 14.9 |
| FEV1 (L) | 1.6 ± 0.6 |
| FEV1, (% predicted) | 54.4 ± 20.0 |
| FEV1 / FVC | 0.7± 0.1 |
| Oxygen saturation (%) | 94± 4 |
| Computed tomography, affected lung lobes#, n (%) | |
| 1 to 3 lobes | 10 (38%) |
| 4 to 6 lobes | 16 (61%) |
| FACED score#, n (%) | |
| Mild (0-2 points) | 13 (50%) |
| Moderate (3-4 points) | 10 (38%) |
| Severe (5-7 points) | 3 (11%) |
| Questionnaires* | |
| St. Georges score (%) | 38 ± 20 |
| Leicester score (3-21) | 18 ± 4 |
| mMRC (0-1) | 17 (60%) |
| mMRC (2 or more) | 11 (39%) |
| Bacterial isolates, n (%) | |
| Pseudomonas aeruginosa | 11 (39%) |
| Staphylococcus aureus | 11 (39%) |
| Haemophilus influenzae | 7 (25%) |
| Acinetobacter sp. | 2 (0%) |
| Patients with exacerbations in the last year#, n (%) 15 (58%) | |
| Laboratory data* | |
| Leukocytes (x 103/µl) | 8 ± 3 |
| Hemoglobin (g/dl) | 14 ± 1 |
| Hematocrit (%) | 43 ± 5 |
| Platelets (x 103/µl) | 280 ± 92 |
| Erythrocyte sedimentation rate (mm/h)^ | 29 ± 22 |
| C-reactive protein (CRP)# | 9±10 |
*Values expressed as mean and standard deviation; °primary malformations, Graft-versus-host disease, allergic bronchopulmonary aspergillosis, asthma, Swyer-James syndrome, bronchiolitis obliterans after bone marrow transplantation, common variable immunodeficiency; BMI, body mass index; FVC, forced vital capacity; FEV1, forced expiratory volume in the first second; COPD, chronic obstructive pulmonary disease; St. Georges score, the higher score, the greater impact on quality of life; Leicester score, the higher score, the lower impact of cough on quality of life; #n=26, ^ n=25.